Atreca Inc Cl A (BCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BCEL | MRNA | BMY | AMGN | GILD |
| Company | Atreca Inc Cl A | Moderna Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.0800 | 106.18 | 44.68 | 265.72 | 65.50 |
| High | 0.0906 | 108.19 | 45.37 | 271.68 | 66.35 |
| Low | 0.0800 | 105.25 | 44.34 | 265.72 | 64.63 |
| Last | 0.0800 | 107.97 | 44.85 | 269.98 | 65.42 |
| Change | -0.0055 | +1.79 | +0.15 | +0.60 | +0.15 |
| % Change | -6.43% | +1.69% | +0.34% | +0.22% | +0.23% |
| Volume | 160,280 | 2,227,958 | 21,237,061 | 2,436,908 | 12,348,617 |
| 20-Day Average Volume | 246,294 | 3,051,643 | 13,203,128 | 2,156,940 | 7,060,701 |
| Previous Close | 0.0855 | 106.18 | 44.70 | 269.38 | 65.27 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0789 | 105.07 | 49.47 | 269.99 | 68.29 |
| 20-Day Raw Stochastic | 53.85% | 58.07% | 5.16% | 40.03% | 9.20% |
| 20-Day Relative Strength | 38.86% | 54.97% | 29.15% | 45.47% | 29.21% |
| Weighted Alpha | -91.66 | -9.40 | -34.43 | +9.45 | -23.49 |
| Today's Opinion | 88% Sell | 100% Buy | 88% Sell | 72% Sell | 100% Sell |
| Previous Opinion | 88% Sell | 100% Buy | 88% Sell | 72% Sell | 100% Sell |
| Last Month's Opinion | 88% Sell | 72% Buy | 8% Buy | 40% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.90% since 04/19/24 | +6.47% since 04/19/24 | -8.34% since 04/19/24 | +0.39% since 04/19/24 | -2.01% since 04/19/24 |
| Low | 0.0693 on 04/23/24 | 99.30 on 04/22/24 | 44.34 on 04/26/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 |
| High | 0.0920 on 04/24/24 | 111.29 on 04/24/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 |
| 1-Month | |||||
| %Chg | unch since 03/26/24 | +0.52% since 03/26/24 | -14.65% since 03/26/24 | -4.18% since 03/26/24 | -9.65% since 03/26/24 |
| Low | 0.0660 on 04/04/24 | 97.00 on 04/03/24 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 |
| High | 0.0920 on 04/24/24 | 115.89 on 04/09/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 |
| 3-Month | |||||
| %Chg | -67.40% since 01/26/24 | +6.05% since 01/26/24 | -9.76% since 01/26/24 | -13.40% since 01/26/24 | -17.73% since 01/26/24 |
| Low | 0.0520 on 03/19/24 | 84.06 on 02/13/24 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 |
| High | 0.3800 on 01/30/24 | 115.89 on 04/09/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 |
| 6-Month | |||||
| %Chg | -61.94% since 10/26/23 | +42.10% since 10/26/23 | -15.33% since 10/26/23 | +0.10% since 10/26/23 | -16.66% since 10/26/23 |
| Low | 0.0520 on 03/19/24 | 62.55 on 11/02/23 | 44.34 on 04/26/24 | 249.70 on 10/31/23 | 64.63 on 04/26/24 |
| High | 0.4448 on 01/12/24 | 115.97 on 01/08/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,388 | 40,654,200 | 90,596,128 | 144,488,960 | 81,266,176 |
| Shares Outstanding, K | 39,624 | 382,880 | 2,026,759 | 536,376 | 1,245,077 |
| Annual Sales | 0 | 6,848,000,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 |
| Annual Net Income | -97,160,000 | -4,714,000,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 2,811,000,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 |
| Last Quarter Net Income | -36,220,000 | 217,000,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 |
| 60-Month Beta | 1.09 | 1.62 | 0.39 | 0.58 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 11/14/23 | 0.55 on 02/22/24 | -4.40 on 04/25/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 05/08/24 | 05/02/24 | 04/25/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | N/A | 04/04/24 | 05/16/24 | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 6.51 | 14.64 | 9.98 |